{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:18:13Z","timestamp":1791616693294,"version":"4.3.4"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA237027"],"award-info":[{"award-number":["R01CA237027"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The role of dysregulation of mRNA alternative splicing (AS) in the development and progression of solid tumors remains to be defined. Here we describe the first comprehensive AS landscape in the spectrum of human prostate cancer (PCa) evolution. We find that the severity of splicing dysregulation correlates with disease progression and establish intron retention as a hallmark of PCa stemness and aggressiveness. Systematic interrogation of 274 splicing-regulatory genes (SRGs) uncovers prevalent genomic copy number variations (CNVs), leading to mis-expression of ~68% of SRGs during PCa development and progression. Consequently, many SRGs are prognostic. Surprisingly, androgen receptor controls a splicing program distinct from its transcriptional regulation. The spliceosome modulator, E7107, reverses cancer aggressiveness and inhibits castration-resistant PCa (CRPC) in xenograft and autochthonous PCa models. Altogether, our studies establish aberrant AS landscape caused by dysregulated SRGs as a hallmark of PCa aggressiveness and the spliceosome as a therapeutic vulnerability for CRPC.<\/jats:p>","DOI":"10.1038\/s41467-020-15815-7","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T06:03:17Z","timestamp":1588140197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":125,"title":["Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8505-8831","authenticated-orcid":false,"given":"Dingxiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4090-5539","authenticated-orcid":false,"given":"Qiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibing","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsueh-Ping","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Tracz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Buonamici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7527-0409","authenticated-orcid":false,"given":"Jianmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5029-1174","authenticated-orcid":false,"given":"Dean G.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,29]]},"reference":[{"key":"15815_CR1","doi-asserted-by":"crossref","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2019. CA Cancer J. Clin. 69, 7\u201334 (2019).","DOI":"10.3322\/caac.21551"},{"key":"15815_CR2","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.stemcr.2017.11.016","volume":"10","author":"D Zhang","year":"2018","unstructured":"Zhang, D. et al. Histone 2B-GFP label-retaining prostate luminal cells possess progenitor cell properties and are intrinsically resistant to castration. Stem Cell Rep. 10, 228\u2013242 (2018).","journal-title":"Stem Cell Rep."},{"key":"15815_CR3","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.trecan.2018.09.003","volume":"4","author":"D Zhang","year":"2018","unstructured":"Zhang, D., Zhao, S., Li, X., Kirk, J. S. & Tang, D. G. Prostate luminal progenitor cells in development and cancer. Trends Cancer 4, 769\u2013783 (2018).","journal-title":"Trends Cancer"},{"key":"15815_CR4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nm.4045","volume":"22","author":"H Beltran","year":"2016","unstructured":"Beltran, H. et al. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat. Med. 22, 298\u2013305 (2016).","journal-title":"Nat. Med."},{"key":"15815_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10798","volume":"7","author":"D Zhang","year":"2016","unstructured":"Zhang, D. et al. Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer. Nat. Commun. 7, 10798 (2016).","journal-title":"Nat. Commun."},{"key":"15815_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/cr.2012.13","volume":"22","author":"DG Tang","year":"2012","unstructured":"Tang, D. G. Understanding cancer stem cell heterogeneity and plasticity. Cell Res. 22, 457\u2013472 (2012).","journal-title":"Cell Res."},{"key":"15815_CR7","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1038\/onc.2015.318","volume":"35","author":"A Sveen","year":"2016","unstructured":"Sveen, A., Kilpinen, S., Ruusulehto, A., Lothe, R. A. & Skotheim, R. I. Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes. Oncogene 35, 2413\u20132427 (2016).","journal-title":"Oncogene"},{"key":"15815_CR8","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/nm.4165","volume":"22","author":"SC Lee","year":"2016","unstructured":"Lee, S. C. & Abdel-Wahab, O. Therapeutic targeting of splicing in cancer. Nat. Med 22, 976\u2013986 (2016).","journal-title":"Nat. Med"},{"key":"15815_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccell.2018.07.001","volume":"34","author":"A Kahles","year":"2018","unstructured":"Kahles, A. et al. Comprehensive analysis of alternative splicing across tumors from 8,705 patients. Cancer Cell 34, 211\u2013224 e216 (2018).","journal-title":"Cancer Cell"},{"key":"15815_CR10","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature14985","volume":"525","author":"TY Hsu","year":"2015","unstructured":"Hsu, T. Y. et al. The spliceosome is a therapeutic vulnerability in MYC-driven cancer. Nature 525, 384\u2013388 (2015).","journal-title":"Nature"},{"key":"15815_CR11","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1101\/gr.199935.115","volume":"26","author":"E Sebestyen","year":"2016","unstructured":"Sebestyen, E. et al. Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks. Genome Res. 26, 732\u2013744 (2016).","journal-title":"Genome Res."},{"key":"15815_CR12","doi-asserted-by":"publisher","first-page":"D1018","DOI":"10.1093\/nar\/gkv1288","volume":"44","author":"M Ryan","year":"2016","unstructured":"Ryan, M. et al. TCGASpliceSeq a compendium of alternative mRNA splicing in cancer. Nucleic Acids Res. 44, D1018\u20131022 (2016).","journal-title":"Nucleic Acids Res."},{"key":"15815_CR13","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41571-018-0085-0","volume":"15","author":"A Paschalis","year":"2018","unstructured":"Paschalis, A. et al. Alternative splicing in prostate cancer. Nat. Rev. Clin. Oncol. 15, 663\u2013675 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"15815_CR14","doi-asserted-by":"publisher","first-page":"E5593","DOI":"10.1073\/pnas.1419161111","volume":"111","author":"S Shen","year":"2014","unstructured":"Shen, S. et al. rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc. Natl Acad. Sci. USA 111, E5593\u20135601 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"15815_CR15","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1261\/rna.051557.115","volume":"21","author":"GP Alamancos","year":"2015","unstructured":"Alamancos, G. P., Pages, A., Trincado, J. L., Bellora, N. & Eyras, E. Leveraging transcript quantification for fast computation of alternative splicing profiles. RNA 21, 1521\u20131531 (2015).","journal-title":"RNA"},{"key":"15815_CR16","first-page":"1011","volume":"163","author":"Cancer Genome Atlas Research Network","year":"2015","unstructured":"Cancer Genome Atlas Research Network The molecular taxonomy of primary prostate. Cancer Cell 163, 1011\u20131025 (2015).","journal-title":"Cancer Cell"},{"key":"15815_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.eururo.2013.08.011","volume":"66","author":"P Rajan","year":"2014","unstructured":"Rajan, P. et al. Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy. Eur. Urol. 66, 32\u201339 (2014).","journal-title":"Eur. Urol."},{"key":"15815_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0426-y","volume":"15","author":"AW Wyatt","year":"2014","unstructured":"Wyatt, A. W. et al. Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer. Genome Biol. 15, 426 (2014).","journal-title":"Genome Biol."},{"key":"15815_CR19","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","volume":"161","author":"D Robinson","year":"2015","unstructured":"Robinson, D. et al. Integrative clinical genomics of advanced prostate cancer. Cell 161, 1215\u20131228 (2015).","journal-title":"Cell"},{"key":"15815_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1158\/1541-7786.MCR-14-0273","volume":"13","author":"AG Sowalsky","year":"2015","unstructured":"Sowalsky, A. G. et al. Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer. Mol. Cancer Res. 13, 98\u2013106 (2015).","journal-title":"Mol. Cancer Res."},{"key":"15815_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.aah4307","volume":"355","author":"P Mu","year":"2017","unstructured":"Mu, P. et al. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Science 355, 84\u201388 (2017).","journal-title":"Science"},{"key":"15815_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"15815_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1892","volume":"3","author":"T Yae","year":"2012","unstructured":"Yae, T. et al. Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell. Nat. Commun. 3, 883 (2012).","journal-title":"Nat. Commun."},{"key":"15815_CR24","doi-asserted-by":"crossref","first-page":"27966","DOI":"10.18632\/oncotarget.15854","volume":"8","author":"AR Lee","year":"2017","unstructured":"Lee, A. R. et al. Alternative RNA splicing of the MEAF6 gene facilitates neuroendocrine prostate cancer progression. Oncotarget 8, 27966\u201327975 (2017).","journal-title":"Oncotarget"},{"key":"15815_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06067-7","volume":"9","author":"Q Li","year":"2018","unstructured":"Li, Q. et al. Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses. Nat. Commun. 9, 3600 (2018).","journal-title":"Nat. Commun."},{"key":"15815_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-015-0168-9","volume":"7","author":"H Dvinge","year":"2015","unstructured":"Dvinge, H. & Bradley, R. K. Widespread intron retention diversifies most cancer transcriptomes. Genome Med. 7, 45 (2015).","journal-title":"Genome Med."},{"key":"15815_CR27","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.stem.2012.03.009","volume":"10","author":"J Qin","year":"2012","unstructured":"Qin, J. et al. The PSA(-\/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration. Cell Stem Cell 10, 556\u2013569 (2012).","journal-title":"Cell Stem Cell"},{"key":"15815_CR28","doi-asserted-by":"publisher","first-page":"14220","DOI":"10.18632\/oncotarget.7303","volume":"7","author":"K Rycaj","year":"2016","unstructured":"Rycaj, K. et al. Longitudinal tracking of subpopulation dynamics and molecular changes during LNCaP cell castration and identification of inhibitors that could target the PSA-\/lo castration-resistant cells. Oncotarget 7, 14220\u201314240 (2016).","journal-title":"Oncotarget"},{"key":"15815_CR29","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nbt.3388","volume":"33","author":"J Choi","year":"2015","unstructured":"Choi, J. et al. A comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs. Nat. Biotechnol. 33, 1173\u20131181 (2015).","journal-title":"Nat. Biotechnol."},{"key":"15815_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1184-4","volume":"18","author":"R Middleton","year":"2017","unstructured":"Middleton, R. et al. IRFinder: assessing the impact of intron retention on mammalian gene expression. Genome Biol. 18, 51 (2017).","journal-title":"Genome Biol."},{"key":"15815_CR31","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.devcel.2017.03.003","volume":"41","author":"C Naro","year":"2017","unstructured":"Naro, C. et al. An orchestrated intron retention program in meiosis controls timely usage of transcripts during germ cell differentiation. Dev. Cell 41, 82\u201393 e84 (2017).","journal-title":"Dev. Cell"},{"key":"15815_CR32","doi-asserted-by":"publisher","first-page":"6817","DOI":"10.1093\/nar\/gkw591","volume":"44","author":"T Ni","year":"2016","unstructured":"Ni, T. et al. Global intron retention mediated gene regulation during CD4+ T cell activation. Nucleic Acids Res. 44, 6817\u20136829 (2016).","journal-title":"Nucleic Acids Res."},{"key":"15815_CR33","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1101\/gr.177790.114","volume":"24","author":"U Braunschweig","year":"2014","unstructured":"Braunschweig, U. et al. Widespread intron retention in mammals functionally tunes transcriptomes. Genome Res. 24, 1774\u20131786 (2014).","journal-title":"Genome Res."},{"key":"15815_CR34","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1158\/1541-7786.MCR-14-0366","volume":"13","author":"ZX Lu","year":"2015","unstructured":"Lu, Z. X. et al. Transcriptome-wide landscape of pre-mRNA alternative splicing associated with metastatic colonization. Mol. Cancer Res. 13, 305\u2013318 (2015).","journal-title":"Mol. Cancer Res."},{"key":"15815_CR35","doi-asserted-by":"publisher","first-page":"W361","DOI":"10.1093\/nar\/gku406","volume":"42","author":"I Paz","year":"2014","unstructured":"Paz, I., Kosti, I., Ares, M. Jr., Cline, M. & Mandel-Gutfreund, Y. RBPmap: a web server for mapping binding sites of RNA-binding proteins. Nucleic Acids Res. 42, W361\u2013367 (2014).","journal-title":"Nucleic Acids Res."},{"key":"15815_CR36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13046-018-0852-x","volume":"37","author":"J Ye","year":"2018","unstructured":"Ye, J. et al. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 37, 212 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"15815_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1101\/gad.247361.114","volume":"29","author":"PL Boutz","year":"2015","unstructured":"Boutz, P. L., Bhutkar, A. & Sharp, P. A. Detained introns are a novel, widespread class of post-transcriptionally spliced introns. Genes Dev. 29, 63\u201380 (2015).","journal-title":"Genes Dev."},{"key":"15815_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1261\/rna.059055.116","volume":"23","author":"M Colombo","year":"2017","unstructured":"Colombo, M., Karousis, E. D., Bourquin, J., Bruggmann, R. & Muhlemann, O. Transcriptome-wide identification of NMD-targeted human mRNAs reveals extensive redundancy between SMG6- and SMG7-mediated degradation pathways. RNA 23, 189\u2013201 (2017).","journal-title":"RNA"},{"key":"15815_CR39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nm.4053","volume":"22","author":"A Kumar","year":"2016","unstructured":"Kumar, A. et al. Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer. Nat. Med. 22, 369\u2013378 (2016).","journal-title":"Nat. Med."},{"key":"15815_CR40","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nature13229","volume":"510","author":"IA Asangani","year":"2014","unstructured":"Asangani, I. A. et al. Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer. Nature 510, 278\u2013282 (2014).","journal-title":"Nature"},{"key":"15815_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2453-4","volume":"16","author":"JR Olsen","year":"2016","unstructured":"Olsen, J. R. et al. Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes. BMC Cancer 16, 377 (2016).","journal-title":"BMC Cancer"},{"key":"15815_CR42","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1128\/MCB.01301-09","volume":"30","author":"I Younis","year":"2010","unstructured":"Younis, I. et al. Rapid-response splicing reporter screens identify differential regulators of constitutive and alternative splicing. Mol. Cell Biol. 30, 1718\u20131728 (2010).","journal-title":"Mol. Cell Biol."},{"key":"15815_CR43","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.cell.2013.03.021","volume":"153","author":"SC Baca","year":"2013","unstructured":"Baca, S. C. et al. Punctuated evolution of prostate cancer genomes. Cell 153, 666\u2013677 (2013).","journal-title":"Cell"},{"key":"15815_CR44","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/ng.2279","volume":"44","author":"CE Barbieri","year":"2012","unstructured":"Barbieri, C. E. et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 44, 685\u2013689 (2012).","journal-title":"Nat. Genet."},{"key":"15815_CR45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nature11125","volume":"487","author":"CS Grasso","year":"2012","unstructured":"Grasso, C. S. et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature 487, 239\u2013243 (2012).","journal-title":"Nature"},{"key":"15815_CR46","doi-asserted-by":"publisher","first-page":"11139","DOI":"10.1073\/pnas.1411446111","volume":"111","author":"H Hieronymus","year":"2014","unstructured":"Hieronymus, H. et al. Copy number alteration burden predicts prostate cancer relapse. Proc. Natl Acad. Sci. USA 111, 11139\u201311144 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"15815_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor, B. S. et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11\u201322 (2010).","journal-title":"Cancer Cell"},{"key":"15815_CR48","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).","journal-title":"Sci. Signal."},{"key":"15815_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12008","volume":"7","author":"P Ulz","year":"2016","unstructured":"Ulz, P. et al. Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer. Nat. Commun. 7, 12008 (2016).","journal-title":"Nat. Commun."},{"key":"15815_CR50","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.ccell.2018.10.016","volume":"34","author":"C Gerhauser","year":"2018","unstructured":"Gerhauser, C. et al. Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories. Cancer Cell 34, 996\u20131011.e1018 (2018).","journal-title":"Cancer Cell"},{"key":"15815_CR51","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.cell.2017.07.005","volume":"170","author":"ER McDonald 3rd","year":"2017","unstructured":"McDonald, E. R. 3rd et al. Project DRIVE: a compendium of cancer dependencies and synthetic lethal relationships uncovered by large-scale, deep RNAi screening. Cell 170, 577\u2013592 e510 (2017).","journal-title":"Cell"},{"key":"15815_CR52","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","volume":"170","author":"A Tsherniak","year":"2017","unstructured":"Tsherniak, A. et al. Defining a cancer dependency map. Cell 170, 564\u2013576 e516 (2017).","journal-title":"Cell"},{"key":"15815_CR53","doi-asserted-by":"publisher","first-page":"6296","DOI":"10.1158\/1078-0432.CCR-13-0485","volume":"19","author":"FA Eskens","year":"2013","unstructured":"Eskens, F. A. et al. Phase I pharmacokinetic and pharmacodynamic study of the first-in-class spliceosome inhibitor E7107 in patients with advanced solid tumors. Clin. Cancer Res. 19, 6296\u20136304 (2013).","journal-title":"Clin. Cancer Res."},{"key":"15815_CR54","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccr.2014.07.010","volume":"26","author":"Y Wang","year":"2014","unstructured":"Wang, Y. et al. The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression. Cancer Cell 26, 374\u2013389 (2014).","journal-title":"Cancer Cell"},{"key":"15815_CR55","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nm.2284","volume":"17","author":"C Liu","year":"2011","unstructured":"Liu, C. et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat. Med. 17, 211\u2013215 (2011).","journal-title":"Nat. Med."},{"key":"15815_CR56","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.celrep.2017.08.012","volume":"20","author":"H Climente-Gonzalez","year":"2017","unstructured":"Climente-Gonzalez, H., Porta-Pardo, E., Godzik, A. & Eyras, E. The functional impact of alternative splicing in cancer. Cell Rep. 20, 2215\u20132226 (2017).","journal-title":"Cell Rep."},{"key":"15815_CR57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"15815_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"15815_CR59","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"15815_CR60","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1089\/1066527041410418","volume":"11","author":"G Yeo","year":"2004","unstructured":"Yeo, G. & Burge, C. B. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J. Comput. Biol. 11, 377\u2013394 (2004).","journal-title":"J. Comput. Biol."},{"key":"15815_CR61","doi-asserted-by":"crossref","unstructured":"Uhlen, M. et al. A pathology atlas of the human cancer transcriptome. Science 357, pii: eaan2507 (2017).","DOI":"10.1126\/science.aan2507"},{"key":"15815_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14270","volume":"8","author":"C Liu","year":"2017","unstructured":"Liu, C. et al. MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes. Nat. Commun. 8, 14270 (2017).","journal-title":"Nat. Commun."},{"key":"15815_CR63","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/nm.4097","volume":"22","author":"SC Lee","year":"2016","unstructured":"Lee, S. C. et al. Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins. Nat. Med. 22, 672\u2013678 (2016).","journal-title":"Nat. Med."},{"key":"15815_CR64","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1535-6108(03)00197-1","volume":"4","author":"K Ellwood-Yen","year":"2003","unstructured":"Ellwood-Yen, K. et al. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 4, 223\u2013238 (2003).","journal-title":"Cancer Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15815-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15815-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15815-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T16:14:05Z","timestamp":1670256845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-15815-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,29]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["15815"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-15815-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,29]]},"assertion":[{"value":"25 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2089"}}